Prenatal presentation of fetal bradycardia and long QT syndrome
- 3 January 2026
- journal article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 68 (1) , 107-115
Abstract
Objectives: Fetal bradycardia may be defined as a ventricular rate more than 2 SD below the gestational‐age‐specific mean. Sinus bradycardia, functional 2:1 atrioventricular block (AVB) and/or polymorphic ventricular tachycardia (VT) are recognized as potential presentations of fetal long QT syndrome (LQTS). The objectives of this study were to describe the associations with LQTS and outcomes of fetuses presenting with isolated sinus bradycardia, 2:1 AVB or VT. Methods: This was a retrospective review of all cases presenting with sinus bradycardia, non‐immune mediated 2:1 AVB or VT on referral to our tertiary fetal cardiology center between January 2018 and November 2023. Cases with maternal anti‐Ro/anti‐La antibodies, blocked atrial ectopic beats or major congenital heart disease were excluded. Data were collected on patient demographics, fetal echocardiography findings, clinical genetic results, family screening and postnatal outcome. The left ventricular isovolumetric relaxation time (LVIRT) and LVIRT normalized as a proportion of cycle length (N‐LVIRT) were derived using pulsed‐wave Doppler tracings to estimate the QT interval. Results: In total, 22 fetuses were included in the study, with a presenting rhythm of sinus bradycardia in 16, 2:1 AVB in two, both sinus bradycardia and 2:1 AVB in two and VT in two. None had a family history of LQTS. Genetic testing was performed in 14 cases of which 12 were tested prenatally. There were 13 cases with a positive LQTS genotype (eight KCNQ1 , one KCNE1 , two KCNH2, one SCN5A and one CALM2 ). Median presenting fetal heart rate (FHR) and FHR Z ‐score in sinus rhythm was 120 (range, 100–139) bpm and −3.04 (range, −4.98 to −0.91), respectively. In the 13 cases with genetically confirmed LQTS, N‐LVIRT and LVIRT were persistently above threshold in two and six cases, respectively. Conclusions: The most common finding in fetuses with persistent sinus bradycardia without major congenital heart disease or autoimmune disease is LQTS. Prenatal genetic testing enables tailored parental counseling and management of the pregnancy. Although N‐LVIRT and LVIRT were not above the threshold values in most cases, they remain important measures for investigation in future studies. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.Keywords
Funding Information
- Diabetes UK (21/0006277)
This publication has 26 references indexed in Scilit:
- Isovolumic Relaxation Time and Repolarization in Fetuses at Risk of Long QT SyndromeJACC: Clinical Electrophysiology, 2023
- Systematic review of long QT syndrome identified during fetal lifeHeart Rhythm, 2022
- Reference Ranges for Pulsed-Wave Doppler of the Fetal Cardiac Inflow and Outflow Tracts from 13 to 36 Weeks’ GestationJournal of the American Society of Echocardiography, 2021
- Prenatal and postnatal diagnosis of Schuurs‐Hoeijmakers syndrome: Case series and review of the literatureAmerican Journal of Medical Genetics Part A, 2020
- Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents With Long QT SyndromeJACC, 2011
- Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT SyndromeJAMA, 2006
- Fetal arrhythmiasUltrasound in Obstetrics & Gynecology, 2006
- MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac ArrhythmiaCell, 1999
- SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndromeCell, 1995
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell, 1995